EdgeEndo and Biolase Announce Plans to Develop
New EdgePRO Laser-Assisted Microfluidic Irrigation Device for Endodontists
Albuquerque, New Mexico, April 20, 2021 –EdgeEndo the global leader in commercializing endodontic products and Biolase, the global leader in dental lasers, announced in association with the American Association of Endodontists (AAE) Annual Meeting beginning on April 21, 2021, the co-development of EdgePRO, a next-generation Laser-Assisted Microfluidic Irrigation device for endodontists. This new Microfluidic Irrigation device is being developed to offer a solution for endodontists seeking more from their current cleaning and disinfection techniques, such as sodium hypochlorite, EDTA, chlorhexidine and 2-in-1 or 3-in-1 irrigation solutions. Biolase anticipates submitting a premarket notification (510(k)) to the Food and Drug Administration for the co-developed device in the second quarter of 2021. The device is not currently available for sale in the United States.
The EdgePRO Laser-Assisted Microfluidic Irrigation Device will build upon Biolase’s patented and proven platform that has been shown to significantly improve debridement, cleaning and disinfection up to 99%[2-4], and removes smear layer[5-9] and biofilms[10,11] using the most advanced laser light sound technology with traditional irrigation solutions or water.
“We had been researching advanced Microfluidic Irrigation technologies in the high-tech endodontic irrigation market for several years and concluded that Biolase would be an ideal business partner for EdgeEndo,” said Dr. Charles Goodis, DDS, EdgeEndo founder and CEO. “Their proprietary Waterlase Er.Cr:YSGG technology has proven to be clinically effective in endodontics over the last 20 years. This is reinforced by the publication of more than 75 research papers and the technology’s use by thousands of dentists around the world to enhance clinical outcomes. Partnering with Biolase will provide us with access to an endodontic-specific, minimally invasive technology, with proprietary and patented radial firing tip technology to incorporate into our EdgePRO product. We are excited about this collaboration and in the near term look forward to developing a technology for endodontists that has the potential to improve patient experiences and clinical outcomes.”
Biolase President and CEO, John Beaver adds, “We are very pleased with the efforts thus far on the design and performance of the EdgePRO as our first OEM laser product. Approximately, 75% of all endodontists routinely use EdgeEndo endodontic files, burs, and bioceramics, providing reach and relationships with the endodontist specialists that will further our goal of making Waterlase technology the standard of care in endodontics. This allows Biolase to focus its commercial channels on other specialties, such as periodontics and pediatrics, in addition to the approximately 200,000 general dentists in the United States. We look forward to a long and beneficial relationship with EdgeEndo.”